Catalyst Event
Merck and Co Inc (MRK) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
3/18/2026, 12:00:00 AM
Merck is scheduled to receive a decision on the expanded label for Bravecto Quantum for dogs on March 18, 2026. Label expansions usually have a minor price impact of 1-5%, scheduled.
Korean Translation
2026년 3월 18일에 반려견용 의약품 브라벡토 퀀텀의 라벨 확대 승인이 예정됨. 라벨 확대는 통상 1-5%의 미미한 주가 영향이 예상됨, 예정됨.
Related Recent Events
ON Semiconductor Corp (ON) · Other
The company announced it will host its Financial Analyst Day on September 16, 2026, to provide updates on company strategy, growth initiatives, and its long-term financial plan. A low impact is estimated as such events typically provide incremental information. This event is scheduled.
9/16/2026, 12:00:00 AM
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release is scheduled for June 12, 2026, which is expected to have a high market impact (>=10%) as it provides the next official update on financial performance scheduled.
6/12/2026, 12:00:00 AM
Dell Technologies Inc (DELL) · Earnings Release
Dell Technologies Fiscal Year 2027 First Quarter results scheduled.
5/28/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
5/24/2026, 12:00:00 AM
Vertiv Holdings Co (VRT) · Other
Vertiv will host its 2026 Investor Conference from May 19-20, 2026, where management will provide updates on strategic initiatives and market trends, and this is expected to cause moderate price volatility, scheduled.
5/19/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The next quarterly earnings release on 2026-05-14 is scheduled.
5/14/2026, 12:00:00 AM